| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028535154 |
| P356 | DOI | 10.1007/S00213-006-0413-4 |
| P698 | PubMed publication ID | 16710714 |
| P2093 | author name string | Wolfgang Gaebel | |
| Stefan Weinmann | |||
| Birgit Janssen | |||
| Birgit Lindel | |||
| F Komaharadi | |||
| Martin Haerter | |||
| P2860 | cites work | Antipsychotic medication adherence: is there a difference between typical and atypical agents? | Q28214337 |
| Compliance in psychoses | Q33735941 | ||
| Practice guideline for the treatment of patients with schizophrenia, second edition. | Q33976372 | ||
| Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature | Q34989186 | ||
| Overview of partial compliance. | Q35609641 | ||
| Choice of maintenance medication for schizophrenia | Q35609650 | ||
| Clinical predictors of relapse following neuroleptic withdrawal | Q41090579 | ||
| Medication compliance among the seriously mentally ill in a public mental health system | Q41363855 | ||
| Medication noncompliance and substance abuse among patients with schizophrenia | Q44098499 | ||
| Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study | Q44132349 | ||
| The concurrent validity of the Global Assessment of Functioning (GAF). | Q44509449 | ||
| Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol | Q46238336 | ||
| The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis | Q46578593 | ||
| The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder | Q48269470 | ||
| Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes. | Q51938136 | ||
| The quest for well-being: a qualitative study of the experience of taking antipsychotic medication. | Q51942353 | ||
| Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. | Q51969983 | ||
| Assessment of insight in psychosis. | Q52035484 | ||
| Substance abuse among the chronic mentally ill. | Q52062642 | ||
| Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures | Q68177319 | ||
| Insight in schizophrenia. Its relationship to acute psychopathology | Q69366786 | ||
| Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine | Q69931911 | ||
| Relationship between insight, educational background and cognition in schizophrenia | Q71445013 | ||
| Predicting medication noncompliance after hospital discharge among patients with schizophrenia | Q73401303 | ||
| Negative symptoms of schizophrenia and compliance with medication | Q73532857 | ||
| Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders | Q73665556 | ||
| Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study | Q74039313 | ||
| Factors influencing compliance in schizophrenia patients | Q75183935 | ||
| P433 | issue | 2 | |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 229-236 | |
| P577 | publication date | 2006-05-19 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders | |
| P478 | volume | 187 |
| Q38348025 | Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia |
| Q41957512 | Antipsychotic agents: efficacy and safety in schizophrenia |
| Q91829749 | Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q33521559 | Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data |
| Q46180105 | Enhancing patient adherence: outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients |
| Q28545127 | Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia |
| Q39292622 | Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. |
| Q39817602 | How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach |
| Q34231559 | Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand |
| Q90409894 | Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study |
| Q42646812 | Long-acting risperidone improves negative symptoms in stable psychotic patients |
| Q37248065 | Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review |
| Q34650576 | Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders |
| Q34231565 | Patient perspectives on antipsychotic treatments and their association with clinical outcomes |
| Q46665905 | Patient-centered care in affective, non-affective, and schizoaffective groups: patients' opinions and attitudes |
| Q22252274 | Reasons for increased substance use in psychosis |
| Q40488575 | Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications |
| Q37041745 | Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia |
| Q37316058 | Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement |
| Q84484206 | [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial] |
Search more.